Literature DB >> 22190580

Genital tract inflammation during early HIV-1 infection predicts higher plasma viral load set point in women.

Lindi Roberts1, Jo-Ann S Passmore, Koleka Mlisana, Carolyn Williamson, Francesca Little, Lisa M Bebell, Gerhard Walzl, Melissa-Rose Abrahams, Zenda Woodman, Quarraisha Abdool Karim, Salim S Abdool Karim.   

Abstract

BACKGROUND: The biggest challenge in human immunodeficiency virus type 1 (HIV-1) prevention in Africa is the high HIV-1 burden in young women. In macaques, proinflammatory cytokine production in the genital tract is necessary for target cell recruitment and establishment of simian immunodeficiency virus (SIV) infection following vaginal inoculation. The purpose of this study was to assess if genital inflammation during early HIV-1 infection predisposes women to rapid disease progression.
METHODS: Inflammatory cytokine concentrations were measured in cervicovaginal lavage (CVL) from 49 women 6, 17, 30, and 55 weeks after HIV-1 infection and from 22 of these women before infection. Associations between genital inflammation and viral load set point and blood CD4 cell counts 12 months after infection were investigated.
RESULTS: Elevated genital cytokine concentrations 6 and 17 weeks after HIV-1 infection were associated with higher viral load set points and, to a lesser extent, with CD4 depletion. CVL cytokine concentrations during early infection did not differ relative to preinfection but were elevated in women who had vaginal discharge, detectable HIV-1 RNA in their genital tracts, and lower blood CD4 counts.
CONCLUSION: Genital inflammation during early HIV-1 infection was associated with higher viral load set point and CD4 depletion, which are markers of rapid disease progression. Strategies aimed at reducing genital inflammation during early HIV-1 infection may slow disease progression.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22190580      PMCID: PMC3244362          DOI: 10.1093/infdis/jir715

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  32 in total

1.  HIV infection-associated immune activation occurs by two distinct pathways that differentially affect CD4 and CD8 T cells.

Authors:  Marta Catalfamo; Michele Di Mascio; Zonghui Hu; Sharat Srinivasula; Vishakha Thaker; Joseph Adelsberger; Adam Rupert; Michael Baseler; Yutaka Tagaya; Gregg Roby; Catherine Rehm; Dean Follmann; H Clifford Lane
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-05       Impact factor: 11.205

Review 2.  The effect of genital tract infections on HIV-1 shedding in the genital tract: a systematic review and meta-analysis.

Authors:  Leigh F Johnson; David A Lewis
Journal:  Sex Transm Dis       Date:  2008-11       Impact factor: 2.830

3.  Impact of mucosal inflammation on cervical human immunodeficiency virus (HIV-1)-specific CD8 T-cell responses in the female genital tract during chronic HIV infection.

Authors:  Pamela P Gumbi; Nonhlanhla N Nkwanyana; Alfred Bere; Wendy A Burgers; Clive M Gray; Anna-Lise Williamson; Margaret Hoffman; David Coetzee; Lynette Denny; Jo-Ann S Passmore
Journal:  J Virol       Date:  2008-06-18       Impact factor: 5.103

4.  Glycerol monolaurate prevents mucosal SIV transmission.

Authors:  Qingsheng Li; Jacob D Estes; Patrick M Schlievert; Lijie Duan; Amanda J Brosnahan; Peter J Southern; Cavan S Reilly; Marnie L Peterson; Nancy Schultz-Darken; Kevin G Brunner; Karla R Nephew; Stefan Pambuccian; Jeffrey D Lifson; John V Carlis; Ashley T Haase
Journal:  Nature       Date:  2009-03-04       Impact factor: 49.962

5.  IL-15 treatment during acute simian immunodeficiency virus (SIV) infection increases viral set point and accelerates disease progression despite the induction of stronger SIV-specific CD8+ T cell responses.

Authors:  Yvonne M Mueller; Duc H Do; Susan R Altork; Carol M Artlett; Edward J Gracely; Christos D Katsetos; Agustin Legido; Francois Villinger; John D Altman; Charles R Brown; Mark G Lewis; Peter D Katsikis
Journal:  J Immunol       Date:  2008-01-01       Impact factor: 5.422

6.  Cytokine levels in HIV infected and uninfected Indian women: correlation with other STAs.

Authors:  Debjani Guha; Ramdas Chatterjee
Journal:  Exp Mol Pathol       Date:  2008-10-28       Impact factor: 3.362

7.  Relationship between levels of inflammatory cytokines in the genital tract and CD4+ cell counts in women with acute HIV-1 infection.

Authors:  Lisa M Bebell; Jo-Ann Passmore; Carolyn Williamson; Koleka Mlisana; Itua Iriogbe; Francois van Loggerenberg; Quarraisha Abdool Karim; Salim Abdool Karim
Journal:  J Infect Dis       Date:  2008-09-01       Impact factor: 5.226

8.  Quantitating the multiplicity of infection with human immunodeficiency virus type 1 subtype C reveals a non-poisson distribution of transmitted variants.

Authors:  M-R Abrahams; J A Anderson; E E Giorgi; C Seoighe; K Mlisana; L-H Ping; G S Athreya; F K Treurnicht; B F Keele; N Wood; J F Salazar-Gonzalez; T Bhattacharya; H Chu; I Hoffman; S Galvin; C Mapanje; P Kazembe; R Thebus; S Fiscus; W Hide; M S Cohen; S Abdool Karim; B F Haynes; G M Shaw; B H Hahn; B T Korber; R Swanstrom; C Williamson
Journal:  J Virol       Date:  2009-02-04       Impact factor: 5.103

9.  Profound CD4+/CCR5+ T cell expansion is induced by CD8+ lymphocyte depletion but does not account for accelerated SIV pathogenesis.

Authors:  Afam Okoye; Haesun Park; Mukta Rohankhedkar; Lia Coyne-Johnson; Richard Lum; Joshua M Walker; Shannon L Planer; Alfred W Legasse; Andrew W Sylwester; Michael Piatak; Jeffrey D Lifson; Donald L Sodora; Francois Villinger; Michael K Axthelm; Joern E Schmitz; Louis J Picker
Journal:  J Exp Med       Date:  2009-06-22       Impact factor: 14.307

10.  Establishing a cohort at high risk of HIV infection in South Africa: challenges and experiences of the CAPRISA 002 acute infection study.

Authors:  Francois van Loggerenberg; Koleka Mlisana; Carolyn Williamson; Sara C Auld; Lynn Morris; Clive M Gray; Quarraisha Abdool Karim; Anneke Grobler; Nomampondo Barnabas; Itua Iriogbe; Salim S Abdool Karim
Journal:  PLoS One       Date:  2008-04-16       Impact factor: 3.240

View more
  39 in total

1.  Genital inflammation and the risk of HIV acquisition in women.

Authors:  Lindi Masson; Jo-Ann S Passmore; Lenine J Liebenberg; Lise Werner; Cheryl Baxter; Kelly B Arnold; Carolyn Williamson; Francesca Little; Leila E Mansoor; Vivek Naranbhai; Douglas A Lauffenburger; Katharina Ronacher; Gerhard Walzl; Nigel J Garrett; Brent L Williams; Mara Couto-Rodriguez; Mady Hornig; W Ian Lipkin; Anneke Grobler; Quarraisha Abdool Karim; Salim S Abdool Karim
Journal:  Clin Infect Dis       Date:  2015-04-21       Impact factor: 9.079

2.  Innate Antibacterial Activity in Female Genital Tract Secretions Is Associated with Increased Risk of HIV Acquisition.

Authors:  Rebecca Pellett Madan; Lindi Masson; Jessica Tugetman; Lise Werner; Anneke Grobler; Koleka Mlisana; Yungtai Lo; Denise Che; Kelly B Arnold; Salim S Abdool Karim; Jo-Ann S Passmore; Betsy C Herold
Journal:  AIDS Res Hum Retroviruses       Date:  2015-07-14       Impact factor: 2.205

3.  Presence of CD8+ T cells in the ectocervical mucosa correlates with genital viral shedding in HIV-infected women despite a low prevalence of HIV RNA-expressing cells in the tissue.

Authors:  Anna Gibbs; Taha Hirbod; Qingsheng Li; Karin Bohman; Terry B Ball; Francis A Plummer; Rupert Kaul; Joshua Kimani; Kristina Broliden; Annelie Tjernlund
Journal:  J Immunol       Date:  2014-03-17       Impact factor: 5.422

4.  Inflammatory cytokine biomarkers to identify women with asymptomatic sexually transmitted infections and bacterial vaginosis who are at high risk of HIV infection.

Authors:  Lindi Masson; Kelly B Arnold; Francesca Little; Koleka Mlisana; David A Lewis; Nonhlanhla Mkhize; Hoyam Gamieldien; Sinaye Ngcapu; Leigh Johnson; Douglas A Lauffenburger; Quarraisha Abdool Karim; Salim S Abdool Karim; Jo-Ann S Passmore
Journal:  Sex Transm Infect       Date:  2015-10-28       Impact factor: 3.519

5.  Type I interferon responses in rhesus macaques prevent SIV infection and slow disease progression.

Authors:  Netanya G Sandler; Steven E Bosinger; Jacob D Estes; Richard T R Zhu; Gregory K Tharp; Eli Boritz; Doron Levin; Sathi Wijeyesinghe; Krystelle Nganou Makamdop; Gregory Q del Prete; Brenna J Hill; J Katherina Timmer; Emma Reiss; Ganit Yarden; Samuel Darko; Eduardo Contijoch; John Paul Todd; Guido Silvestri; Martha Nason; Robert B Norgren; Brandon F Keele; Srinivas Rao; Jerome A Langer; Jeffrey D Lifson; Gideon Schreiber; Daniel C Douek
Journal:  Nature       Date:  2014-07-09       Impact factor: 49.962

6.  Antiviral activity of genital tract secretions after oral or topical tenofovir pre-exposure prophylaxis for HIV-1.

Authors:  Betsy C Herold; Charlene S Dezzutti; Barbra A Richardson; Jeanne Marrazzo; Pedro M M Mesquita; Colleen Carpenter; Ashley Huber; Nicolette Louissaint; Mark A Marzinke; Sharon L Hillier; Craig W Hendrix
Journal:  J Acquir Immune Defic Syndr       Date:  2014-05-01       Impact factor: 3.731

7.  Prevalence and Associated Factors of Genital and Sexually Transmitted Infections in Married Women of Iran.

Authors:  Elahe Ahmadnia; Roghieh Kharaghani; Azam Maleki; Azar Avazeh; Saeideh Mazloomzadeh; Tahereh Sedaghatpisheh; Ahmad Jalilvand; Behnaz Molae
Journal:  Oman Med J       Date:  2016-11

Review 8.  Soluble mediators of inflammation in HIV and their implications for therapeutics and vaccine development.

Authors:  Sheila M Keating; Evan S Jacobs; Philip J Norris
Journal:  Cytokine Growth Factor Rev       Date:  2012-06-27       Impact factor: 7.638

9.  Gardiquimod: a Toll-like receptor-7 agonist that inhibits HIV type 1 infection of human macrophages and activated T cells.

Authors:  Maarten Buitendijk; Susan K Eszterhas; Alexandra L Howell
Journal:  AIDS Res Hum Retroviruses       Date:  2013-02-05       Impact factor: 2.205

10.  Plasma and mucosal HIV viral loads are associated with genital tract inflammation in HIV-infected women.

Authors:  Betsy C Herold; Marla J Keller; Qiuhu Shi; Donald R Hoover; Colleen A Carpenter; Ashley Huber; Urvi M Parikh; Kathy J Agnew; Howard Minkoff; Christine Colie; Marek J Nowicki; Gypsyamber DʼSouza; D Heather Watts; Kathryn Anastos
Journal:  J Acquir Immune Defic Syndr       Date:  2013-08-01       Impact factor: 3.731

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.